Skip to main content
Log in

Modern Approaches to the Development of Standard Samples of Drugs

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

This review addresses the history of the creation of standard samples (SS) around the world and in Russia, along with studies of the current condition of the state system for standardization of medicinal products (MP) based on the use of SS. Standardization in the area of drugs is directed to guaranteeing the quality of the items standardized, which includes products (raw materials, other materials, ready MP, etc.), services, and processes. The continuing development of manufacturing technologies and the discovery of novel MP increases the need for standard samples, as drug quality control involves the use of complex, highly effective, specific, and precise physicochemical and biological analysis methods.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. V. L. Dorofeev and A. P. Arzamastsev, Vopr. Biol. Med. Farm. Khim., 8(5), 6 – 10 (2010).

    Google Scholar 

  2. European Pharmacopoeia, 8th Edition, European Department for the Quality of Medicines, Strasbourg, and France (2017).

  3. GLP Good Laboratory Practice, March 1, 2010, GOSTR-53434-2009.

  4. Federal Law of the Russian Federation April 12, 2010, No. 61-FZ Medicines [in Russian], Moscow (2010).

  5. Federal Law of the Russian Federation, December 22, 2014 No. 429-FZ, Introduction of Amendments to Federal Law on Medicines [in Russian], Moscow (2014).

  6. European Pharmacopoeia Chemical Reference Substance, CRS, EDQM (2014).

  7. The United States Pharmacopeia 40 – National Formulary 35, Reissue (2018).

  8. ISO – the International Organization for Standardization, Guide 34: General Requirements for the Competence of Reference Material Producers (2009).

  9. World Health Organization, International Chemical Reference Substances, Available from: https://goo.gl/8tfBJS.

  10. A. V. Kozlovich, V. N. Kotikov, L. V. Korsun, et al., Vedom. NTsÉSMP, 7(4), 242 – 250 (2017).

  11. British Pharmacopoeia 2016, H. M. Stationary Office, London (2009).

  12. USSR State Pharmacopeia [in Russian], Meditsina, Moscow (1968), X edition.

  13. ISO – the International Organization for Standardization, Reference Materials – Guidance on, and Keywords Used for, SS categorization (2009).

  14. ICH Harmonized Tripartite Guideline. Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients Q7, 10 November (2000).

  15. ISO – the International Organization for Standardization, ISO Guide 30: Terms and Definitions Used in Connection with Reference Materials (1992).

  16. GOST R ISO 9001-2001, Requirements for Quality Management Systems [in Russian], IPKJ Standards Press, Moscow (2001).

  17. ISO – the International Organization for Standardization, Guide 31: Reference Materials – Contents of Certificates and Labels (2000).

  18. ISO – the International Organization for Standardization, Guide 33: Uses of Certified Reference Materials (2000).

  19. ISO - the International Organization for Standardization, Guide 35: Reference Materials – General and Statistic Principles for Certification (2006).

  20. State Pharmacopeia of the Russian Federation [in, Russian], Moscow (2018), XIV edition (online version).

  21. The International Pharmacopoeia, WHO, Geneva (2006), Vol. 1 – 2; 4th edition.

  22. The International Pharmacopoeia, WHO, Geneva (2008), Vol. 1 – 2, including First Supplement; 4th edition.

  23. V. I. Gegechkori, O. Yu. Shchepochkina, B. M. Pyatin, et al., Vopr. Obespech. Kach. Lek. Sredstv., No. 5, 18 – 21 (2014).

  24. Yu. V. Olefir, E. I. Sakanyan, A. I. Luttseva, et al., Khim.-Farm. Zh., 52(10), 59 – 64 (2018); Pharm. Chem. J., 52(10), 873 – 877 (2018).

  25. Yu. V. Olefir, E. I. Sakanyan, L. I. Shishova, et al., Khim.-Farm. Zh., 52(11), 48 – 54 (2018); Pharm. Chem. J., 52(11), 936 – 941 (2018).

  26. Yu. V. Olefir, E. I. Sakanyan, N. S. Tereshina, et al., Khim.-Farm. Zh., 52(4), 35 – 39 (2018); Pharm. Chem. J., 52(4), 339 – 342 (2018).

  27. V. I. Gegechkori, O. Yu. Shchepochkina, G. M. Rodionova, et al., Biofarm. Zh., 7(6), 43 – 48 (2015).

    CAS  Google Scholar 

  28. V. I. Gegechkori, O. Yu. Shchepochkina, B. M. Pyatin, et al., Estestv. Tekhn. Nauk., 10(88), 201 – 205 (2015).

    Google Scholar 

  29. V. I. Gegechkori, V. A. Kokorekin, O. Yu. Shchepochkina, et al., Biofarm. Zh., 8(3), 37 – 43 (2016).

    CAS  Google Scholar 

  30. V. I. Gegechkori, O. Yu. Shchepochkina, L. N. Grushevskaya, et al., Farmatsiya, 65(1), 3 – 6 (2016).

    Google Scholar 

  31. A. P. Arzamastsev, N. P. Sadchikova, and V. L. Bagirova, Khim.-Farm. Zh., No. 11, 46 – 48 (2000).

  32. V. A. Merkulov, E. I. Sakanyan, R. A. Volkova, et al., Khim.-Farm. Zh., 50(4), 40 – 43 (2016); Pharm. Chem. J., 50(4), 258 – 261 (2016).

  33. S. Kaitel’, Vedom. NTsÉSMP, 2, 8 – 14 (2016).

    Google Scholar 

  34. Yu. V. Olefir, E. I. Sakanyan, and T. B. Shemeryankina, et al., Khim.-Farm. Zh., 52(8), 56 – 60 (2018); Pharm. Chem. J., 52(8), 744 – 748 (2018).

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. I. Gegechkori.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 54, No. 7, pp. 10 – 10, July, 2020.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shchepochkina, O.Y., Gegechkori, V.I., Prokof’eva, V.I. et al. Modern Approaches to the Development of Standard Samples of Drugs. Pharm Chem J 54, 761–765 (2020). https://doi.org/10.1007/s11094-020-02267-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-020-02267-y

Keywords

Navigation